Andrew Orth
Net worth: 15 568 $ as of 2024-04-29
Profile
Andrew C.
Orth worked as a Senior Vice President & Head-US Business at Alnylam Pharmaceuticals, Inc. and later as a Chief Commercial Officer at Krystal Biotech, Inc. He holds an MBA from Cornell University and an undergraduate degree from the University of Wisconsin.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
KRYSTAL BIOTECH, INC.
0.00% | 2023-06-08 | 100 ( 0.00% ) | 15 568 $ | 2024-04-29 |
Former positions of Andrew Orth
| Companies | Position | End |
|---|---|---|
| KRYSTAL BIOTECH, INC. | Corporate Officer/Principal | 2023-08-01 |
| ALNYLAM PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Training of Andrew Orth
| Cornell University | Masters Business Admin |
| University of Wisconsin | Undergraduate Degree |
Experiences
Positions held
Connections
11
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| KRYSTAL BIOTECH, INC. | Health Technology |
| ALNYLAM PHARMACEUTICALS, INC. | Health Technology |
- Stock Market
- Insiders
- Andrew Orth
